Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-03-14 14:38:08
Reporting Period:
Filing Date:
Accepted Time:
2016-03-14 14:38:08
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1443692 Harold Jacob Haadmur Mebuyon 26, Harnof
Jerusalem L3 95403
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-03-10 8,500 $6.45 16,396 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 700 Indirect By wholly-owned corporation
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.41 to $6.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.